The global non-steroidal anti-inflammatory pain patches market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Non-steroidal anti-inflammatory pain patches are used to relieve severe pain in people. The major factor driving the demand for non-inflammatory pain patches include the increasing prevalence of chronic pain across the globe. As per the Center for Disease Control and Prevention (CDC), in 2019, 20.4% of adults had chronic pain and 7.4% (or 36.4% of adults who had chronic pain) of adults had high impact chronic pain that frequently limited life or work activities in the US. Additionally, as per the same source, chronic pain and high-impact chronic pain increases with age and were highest among adults aged 65 and over in the US in 2019.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/non-steroidal-anti-inflammatory-pain-patches-market
Furthermore, the prevalence of chronic pain was highest among women with 21.7% and non-Hispanic white adults with 23.6% along with those aged 65 and over with 30.8%. Hence, the rising prevalence of chronic pain is driving the demand for non-steroidal anti-inflammatory pain patches owing to their application as a pain reliever which in turn is driving the growth of the market. Furthermore, the market is growing due to new product development. For instance, in January 2021, a Duke-led team of scientists developed a bio-compatible surgical patch that releases non-opioid painkillers. It provides a controlled release of a drug directly to the site of a wound for days and then dissolves away and works by blocking the enzyme COX-2 (cyclooxygenase-2,) that drives pain and inflammation.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Disease Indication
- By Distribution Channel
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., GlaxoSmithKline plc, and Cadila Healthcare Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Non-Steroidal Anti Inflammatory Pain Patches Market Report by Segment
By Disease Indication
- Arthritis
- Migraine
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
A full report of Non-Steroidal Anti Inflammatory Pain Patches Market is available at: https://www.omrglobal.com/industry-reports/non-steroidal-anti-inflammatory-pain-patches-market
Non-Steroidal Anti Inflammatory Pain Patches Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- GlaxoSmithKline plc
- Cadila Healthcare Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
